TITLE:
An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)

CONDITION:
Diabetes Mellitus, Type 2

INTERVENTION:
sitagliptin

SUMMARY:

      The purpose of this study is to determine the safety and tolerability of an investigational
      drug in patients with Type 2 Diabetes Mellitus (a specific type of diabetes) and Chronic
      Renal Insufficiency (inadequate kidney function).
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Patients who are at least 18 years of age diagnosed with type 2 diabetes mellitus
             (T2DM) (a specific type of diabetes).

          -  Patient has renal (kidney) insufficiency (inadequate kidney function)

        Exclusion Criteria:

          -  Patient has had heart problems (such as a heart attack or chest pain) or stroke
             within the past 6 months or any condition or therapy which, in the opinion of the
             investigator, may not be in the patient's best interest to participate.

          -  Pregnant or breast feeding
      
